Mineral Bone Disorder in Dialysis (MBDialysis)

Çanakkale Onsekiz Mart University

Status: Completed

Conditions: Chronic Kidney Failure; Hemodialysis; Dialysis; Chronic Kidney Disease-Mineral and Bone Disorder

Treatments: Other: Hemodialysis or peritoneal Dialysis

Study type: Observational

Funder types: Other

Identifiers

NCT07212972

TZ-B

Details and patient eligibility

About

This study was conducted with 167 dialysis patients at Erciyes University Faculty of Medicine, Department of Internal Medicine, Department of Nephrology, and Dialysis Unit, with the approval of the Ethics Committee of Erciyes University Medical Faculty (date: 25.09.2019, no: 2019/673).

Patients aged ≥18 years, undergoing dialysis treatment, and having available data on serum calcium, phosphorus, parathormone, albumin, hemoglobin, blood urea nitrogen (BUN), creatinine, and dialysate calcium levels within the last six months were included in the study.

Enrollment: 167 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Age ≥ 18 years,
• Diagnosed with chronic kidney disease (CKD) and undergoing dialysis treatment (hemodialysis or peritoneal dialysis)
• Availability of laboratory results within the last 6 months: serum calcium, phosphorus, parathormone, albumin, hemoglobin, blood urea nitrogen (BUN), creatinine, and dialysate calcium
• Patient consent to participate

Exclusion criteria

• Age < 18 years
• Patients not on dialysis treatment
• Missing or incomplete laboratory data
• History of malignancy, acute infection, or other systemic diseases interfering with mineral and bone metabolism
• Patients who did not provide consent or could not complete the questionnaire

Trial design

167 participants in 1 patient group

dialysis

Description:

167 patients diagnosed with CKD and undergoing HD or PD were included in the study

Treatment:

Other: Hemodialysis or peritoneal Dialysis